Introduction
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Overview
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Therapeutics Development
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Therapeutics Assessment
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Companies Involved in Therapeutics Development
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drug Profiles
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Dormant Products
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Discontinued Products
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by Alteogen Inc, 2021
Pipeline by Amgen Inc, 2021
Pipeline by Celltrion Inc, 2021
Pipeline by Chengdu Kanghong Pharmaceuticals Group Co Ltd, 2021
Pipeline by Cinnagen Co, 2021
Pipeline by Clover Biopharmaceuticals, 2021
Pipeline by Formycon AG, 2021
Pipeline by GlycoNex Inc, 2021
Pipeline by Hexal AG, 2021
Pipeline by Huons Global Co Ltd, 2021
Pipeline by i2 Pharmaceuticals Inc, 2021
Pipeline by Johnson & Johnson, 2021
Pipeline by Kidswell Bio Corp, 2021
Pipeline by Lupin Ltd, 2021
Pipeline by Luye Pharma Group Ltd, 2021
Pipeline by Oncosimis Biotech Pvt Ltd, 2021
Pipeline by Oxurion NV, 2021
Pipeline by Panolos Bioscience, 2021
Pipeline by PharmAbcine Inc, 2021
Pipeline by Prestige BioPharma Ltd, 2021
Pipeline by Regeneron Pharmaceuticals Inc, 2021
Pipeline by Rophibio Inc, 2021
Pipeline by Sam Chun Dang Pharm Co Ltd, 2021
Pipeline by Samsung Bioepis Co Ltd, 2021
Dormant Projects, 2021
Discontinued Products, 2021

List of Figures
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Alteogen Inc
• Amgen Inc
• Celltrion Inc
• Chengdu Kanghong Pharmaceuticals Group Co Ltd
• Cinnagen Co
• Clover Biopharmaceuticals
• Formycon AG
• GlycoNex Inc
• Hexal AG
• Huons Global Co Ltd
• i2 Pharmaceuticals Inc
• Johnson & Johnson
• Kidswell Bio Corp
• Lupin Ltd
• Luye Pharma Group Ltd
• Oncosimis Biotech Pvt Ltd
• Oxurion NV
• Panolos Bioscience
• PharmAbcine Inc
• Prestige BioPharma Ltd
• Regeneron Pharmaceuticals Inc
• Rophibio Inc
• Sam Chun Dang Pharm Co Ltd
• Samsung Bioepis Co Ltd